Lygos

Lygos is a commercial-stage synthetic biology company that engineers and scales sustainable specialty chemicals for industrial and consumer markets. The company differentiates itself by prioritizing performance and cost-effectiveness alongside biodegradability, with its lead product, Soltellus™, already applied to over 350,000 acres in agriculture and incorporated into major home care brands. By integrating material science, chemistry, and application expertise within a capital-efficient partnership model, Lygos aims to replace petrochemicals and toxic processes across supply chains, driving adoption through proven commercial traction and tangible customer value.

Proprietary synthetic biology and metabolic engineering platform using engineered microbes to ferment renewable feedstocks into high-performance, biodegradable specialty chemicals.

Lygos competes with large petrochemical incumbents (e.g., BASF, Dow) and a growing field of synthetic biology firms like Ginkgo Bioworks (platform), Zymergen (historically), and Genomatica, which also engineer microbes for chemical production. Its differentiation lies in its intense focus on application performance and commercial scale from the outset, coupled with a collaborative, asset-light business model.